UCLOUDLINK GROUP INC (UCL) Fundamental Analysis & Valuation

NASDAQ:UCL • US90354D1046

Current stock price

1.245 USD
-0.06 (-4.96%)
Last:

This UCL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. UCL Profitability Analysis

1.1 Basic Checks

  • In the past year UCL was profitable.
  • In multiple years UCL reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: UCL reported negative operating cash flow in multiple years.
UCL Yearly Net Income VS EBIT VS OCF VS FCFUCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • UCL has a better Return On Assets (9.29%) than 100.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 21.87%, UCL belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
  • UCL's Return On Invested Capital of 19.47% is amongst the best of the industry. UCL outperforms 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for UCL is significantly above the industry average of 7.50%.
  • The last Return On Invested Capital (19.47%) for UCL is above the 3 year average (17.58%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.29%
ROE 21.87%
ROIC 19.47%
ROA(3y)7.09%
ROA(5y)-18.12%
ROE(3y)20.15%
ROE(5y)-76.54%
ROIC(3y)17.58%
ROIC(5y)N/A
UCL Yearly ROA, ROE, ROICUCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200 -200

1.3 Margins

  • UCL's Profit Margin of 7.74% is fine compared to the rest of the industry. UCL outperforms 63.64% of its industry peers.
  • The Operating Margin of UCL (9.78%) is comparable to the rest of the industry.
  • Looking at the Gross Margin, with a value of 52.40%, UCL is in line with its industry, outperforming 40.91% of the companies in the same industry.
  • UCL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.78%
PM (TTM) 7.74%
GM 52.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.86%
GM growth 5Y10.66%
UCL Yearly Profit, Operating, Gross MarginsUCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. UCL Health Analysis

2.1 Basic Checks

  • UCL has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • UCL has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, UCL has more shares outstanding
  • The debt/assets ratio for UCL has been reduced compared to a year ago.
UCL Yearly Shares OutstandingUCL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
UCL Yearly Total Debt VS Total AssetsUCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • UCL has an Altman-Z score of -1.67. This is a bad value and indicates that UCL is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -1.67, UCL is not doing good in the industry: 86.36% of the companies in the same industry are doing better.
  • UCL has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
  • UCL has a better Debt to Equity ratio (0.25) than 86.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -1.67
ROIC/WACC2.35
WACC8.28%
UCL Yearly LT Debt VS Equity VS FCFUCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 1.67 indicates that UCL should not have too much problems paying its short term obligations.
  • The Current ratio of UCL (1.67) is better than 90.91% of its industry peers.
  • A Quick Ratio of 1.55 indicates that UCL should not have too much problems paying its short term obligations.
  • With an excellent Quick ratio value of 1.55, UCL belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.67
Quick Ratio 1.55
UCL Yearly Current Assets VS Current LiabilitesUCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. UCL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.33% over the past year.
  • The Revenue for UCL has decreased by -11.12% in the past year. This is quite bad
  • The Revenue has been decreasing by -1.89% on average over the past years.
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-11.12%
Revenue growth 3Y4.44%
Revenue growth 5Y-1.89%
Sales Q2Q%-14.6%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-55.81%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.38%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UCL Yearly Revenue VS EstimatesUCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
UCL Yearly EPS VS EstimatesUCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.5 -1

More info and screens

Find the best growth stocksShow best growing peers

4

4. UCL Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 7.78, the valuation of UCL can be described as very cheap.
  • Based on the Price/Earnings ratio, UCL is valued cheaply inside the industry as 95.45% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.18, UCL is valued rather cheaply.
  • UCL is valuated rather expensively with a Price/Forward Earnings ratio of 17.61.
  • 77.27% of the companies in the same industry are cheaper than UCL, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 37.96. UCL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.78
Fwd PE 17.61
UCL Price Earnings VS Forward Price EarningsUCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UCL Per share dataUCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • The decent profitability rating of UCL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. UCL Dividend Analysis

5.1 Amount

  • No dividends for UCL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

UCL Fundamentals: All Metrics, Ratios and Statistics

UCLOUDLINK GROUP INC

NASDAQ:UCL (4/14/2026, 11:00:01 AM)

1.245

-0.06 (-4.96%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)03-18
Earnings (Next)05-19
Inst Owners17.56%
Inst Owner Change0%
Ins Owners10.9%
Ins Owner Change0%
Market Cap46.85M
Revenue(TTM)81.45M
Net Income(TTM)6.30M
Analysts80
Price Target8.16 (555.42%)
Short Float %0.26%
Short Ratio0.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)528.05%
Min EPS beat(2)-32.01%
Max EPS beat(2)1088.12%
EPS beat(4)2
Avg EPS beat(4)276.4%
Min EPS beat(4)-32.01%
Max EPS beat(4)1088.12%
EPS beat(8)5
Avg EPS beat(8)125.83%
EPS beat(12)7
Avg EPS beat(12)86.47%
EPS beat(16)8
Avg EPS beat(16)32.45%
Revenue beat(2)0
Avg Revenue beat(2)-4.9%
Min Revenue beat(2)-5.23%
Max Revenue beat(2)-4.56%
Revenue beat(4)1
Avg Revenue beat(4)-6.1%
Min Revenue beat(4)-16.59%
Max Revenue beat(4)2%
Revenue beat(8)4
Avg Revenue beat(8)-3.2%
Revenue beat(12)5
Avg Revenue beat(12)-3.01%
Revenue beat(16)7
Avg Revenue beat(16)-2.39%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-75%
EPS NQ rev (3m)-75%
EPS NY rev (1m)240%
EPS NY rev (3m)75%
Revenue NQ rev (1m)-13.51%
Revenue NQ rev (3m)-13.51%
Revenue NY rev (1m)-0.55%
Revenue NY rev (3m)-12.62%
Valuation
Industry RankSector Rank
PE 7.78
Fwd PE 17.61
P/S 0.58
P/FCF N/A
P/OCF N/A
P/B 1.63
P/tB 1.66
EV/EBITDA N/A
EPS(TTM)0.16
EY12.85%
EPS(NY)0.07
Fwd EY5.68%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.16
BVpS0.77
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.66
Profitability
Industry RankSector Rank
ROA 9.29%
ROE 21.87%
ROCE 25.65%
ROIC 19.47%
ROICexc N/A
ROICexgc N/A
OM 9.78%
PM (TTM) 7.74%
GM 52.4%
FCFM N/A
ROA(3y)7.09%
ROA(5y)-18.12%
ROE(3y)20.15%
ROE(5y)-76.54%
ROIC(3y)17.58%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)24.7%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.86%
GM growth 5Y10.66%
F-ScoreN/A
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.67
Quick Ratio 1.55
Altman-Z -1.67
F-ScoreN/A
WACC8.28%
ROIC/WACC2.35
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-55.81%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.12%
Revenue growth 3Y4.44%
Revenue growth 5Y-1.89%
Sales Q2Q%-14.6%
Revenue Next Year9.38%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y81.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

UCLOUDLINK GROUP INC / UCL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of UCLOUDLINK GROUP INC (UCL) stock?

ChartMill assigns a fundamental rating of 4 / 10 to UCL.


Can you provide the valuation status for UCLOUDLINK GROUP INC?

ChartMill assigns a valuation rating of 4 / 10 to UCLOUDLINK GROUP INC (UCL). This can be considered as Fairly Valued.


Can you provide the profitability details for UCLOUDLINK GROUP INC?

UCLOUDLINK GROUP INC (UCL) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for UCL stock?

The Price/Earnings (PE) ratio for UCLOUDLINK GROUP INC (UCL) is 7.78 and the Price/Book (PB) ratio is 1.63.


What is the financial health of UCLOUDLINK GROUP INC (UCL) stock?

The financial health rating of UCLOUDLINK GROUP INC (UCL) is 4 / 10.